Regeneron acquires 23andMe for $256 million following its bankruptcy. The deal includes DNA data access, raising privacy ...

Share on Facebook Share on Twitter Jaelen Johnston continues to prove that it’s not how you start, it’s how you finish. On ...

In March, 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.

Investors burned by President Trump’s trade fight now have to contend with a spending megabill that risks swelling the ...

Dow Jones Top Company Headlines at 5 AM ET: Chinese Battery Giant CATL’s Shares Surge on Hong Kong Debut | Honda ... The listing comes as risk appetite has returned to global markets as trade ...

Regeneron Pharmaceuticals is set to acquire 23andMe for $256 million following its bankruptcy filing due to declining demand ...

Regeneron Pharmaceuticals said in a press release yesterday that it would acquire 23andMe’s Personal Genome Service (PGS), ...

South San Francisco, California-based 23andMe filed for bankruptcy last month, seeking to sell its business at auction after ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...